| Northeast Optometry Llc | |
|
60 Massachusetts Ave, Arlington, MA 02474-8621 | |
| (781) 990-8195 | |
| Not Available |
| Full Name | Northeast Optometry Llc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 60 Massachusetts Ave, Arlington, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922732684 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Primary |
| Provider Name | Josephine W Ko |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1053934935 PECOS PAC ID: 8426453978 Enrollment ID: I20210820001136 |
News Archive
Keryx Biopharmaceuticals, Inc. today announced that data from its Phase 1/2 clinical trial of KRX-0401 (perifosine) in combination with bortezomib (+/- dexamethasone) has been selected for poster presentation at the upcoming 51st Annual Meeting of the American Society of Hematology (ASH), to be held in New Orleans from December 5-8, 2009.
United Arab Emirates and Kingdom of Saudi Arabia institutions will have access to a single, comprehensive set of stroke certification services through a new collaboration between the Middle East and North Africa Stroke Organization and the American Stoke Association.
For the study the researchers looked at coffee consumption and endometrial cancer risk in more than 67,000 women aged between 34 and 59 enrolled in the long-running Nurses' Health Study. The researchers found that women who took more than four cups of coffee a day over a 26-year period were 25 percent less likely to get the cancer.
As the weather gets warmer, many parents will turn to pools to keep their family cool. Due to their low cost and ease of use, portable pools - which include wading pools, inflatable pools and soft-sided, self-rising pools - have become an increasingly popular alternative to expensive in-ground pools or water park visits.
Arena Pharmaceuticals, Inc. reported today data from the pivotal BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management) Phase 3 trial that demonstrate improvements in patients' body composition, cardiovascular risk factors and quality of life. These findings add to the previously announced top-line BLOSSOM data that showed highly significant weight loss with lorcaserin over one year of treatment in 4,008 patients.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Northeast Optometry Llc 539 Clinton Rd, Chestnut Hill, MA 02467-1418 Ph: () - | Northeast Optometry Llc 60 Massachusetts Ave, Arlington, MA 02474-8621 Ph: (781) 990-8195 |
News Archive
Keryx Biopharmaceuticals, Inc. today announced that data from its Phase 1/2 clinical trial of KRX-0401 (perifosine) in combination with bortezomib (+/- dexamethasone) has been selected for poster presentation at the upcoming 51st Annual Meeting of the American Society of Hematology (ASH), to be held in New Orleans from December 5-8, 2009.
United Arab Emirates and Kingdom of Saudi Arabia institutions will have access to a single, comprehensive set of stroke certification services through a new collaboration between the Middle East and North Africa Stroke Organization and the American Stoke Association.
For the study the researchers looked at coffee consumption and endometrial cancer risk in more than 67,000 women aged between 34 and 59 enrolled in the long-running Nurses' Health Study. The researchers found that women who took more than four cups of coffee a day over a 26-year period were 25 percent less likely to get the cancer.
As the weather gets warmer, many parents will turn to pools to keep their family cool. Due to their low cost and ease of use, portable pools - which include wading pools, inflatable pools and soft-sided, self-rising pools - have become an increasingly popular alternative to expensive in-ground pools or water park visits.
Arena Pharmaceuticals, Inc. reported today data from the pivotal BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management) Phase 3 trial that demonstrate improvements in patients' body composition, cardiovascular risk factors and quality of life. These findings add to the previously announced top-line BLOSSOM data that showed highly significant weight loss with lorcaserin over one year of treatment in 4,008 patients.
› Verified 3 days ago
Anthony Phamduy, OD Optometrist Medicare: Medicare Enrolled Practice Location: 1328 Massachusetts Ave, Arlington, MA 02476 Phone: 781-488-0094 Fax: 781-777-2803 | |
Dr. John Winston Archibald, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 476 Mass Ave, Arlington, MA 02474 Phone: 781-648-2342 Fax: 781-648-2346 | |
Dr. Roy Edward Baker, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 11 Jason St, Arlington, MA 02476 Phone: 178-164-8342 | |
The Vision Standard Optometrist Medicare: Not Enrolled in Medicare Practice Location: 60 Massachusetts Ave, Arlington, MA 02474 Phone: 781-361-0141 | |
Vision Standard Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 60 Massachusetts Ave, Arlington, MA 02474 Phone: 781-316-0141 | |
Myeyedr. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1328 Massachusetts Ave, Arlington, MA 02476 Phone: 617-484-1414 | |
Megan Lynn Lopez, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1040 Mass Ave, Arlington, MA 02476 Phone: 781-876-2020 |